Alphatec Holdings Inc. SWOT Analysis and Company Tech Intelligence Report 2018

Report Name: Alphatec Holdings Inc. Profile – Overview, History, SWOT Analysis, Products/Services, Facts, Financials, Key Executives, Competitors, Tech Intelligence, IT Outsourcing, IT Management, Recent Developments and Strategy Evaluation

Alphatec Holdings Inc. Report – Publisher: Research Cosmos

Price Scheme of the Report:

Single User License – USD 150

Team License – USD 175

Corporate License – USD 250

Alphatec Holdings Inc. – Business Description:

Alphatec Holdings Inc. is a US-based medical technology company, which designs, develops, manufactures, and markets a range of products for the surgical treatment of spine disorders. The company has operations in the US, Asia, Australia and Europe. The company’s product portfolio and pipeline addresses the cervical, thoracolumbar, and intervertebral regions of the spine and covers a range of spinal disorders and surgical procedures. Its products and systems are made of titanium, titanium alloy, stainless steel, cobalt chrome, ceramic, allograft, and polyetheretherketone (PEEK). Alphatec provides a range of products including cervical and cervico-thoracic products which include Trestle Luxe Anterior Cervical Plate System, Solanas Posterior Cervico/Thoracic Fixation System and Avalon Occipital Plate and Pegasus Anchored Cervical Interbody; thoracolumbar fixation products which include Arsenal Degenerative System, Arsenal CBx Cortical Bone Fixation System, Zodiac Degenerative Spinal Fixation System, Zodiac Deformity Spinal Fixation System and OsseoScrew Spinal Fixation System; spinal spacers which include Battalion Universal Spacer System, Novel PEEK and Titanium Spinal Spacers, and Alphatec Solus Locking ALIF Spinal Spacer; minimally invasive surgery (MIS) products which include Illico Minimally Invasive Surgery System and BridgePoint Spinous Process Fixation System; and biologics which include Neocore Osteoconductive Matrix. The company markets the products under the brands including Arsenal, Battalion, Novel, Samarys, Solus, Pegasus, Trestle Luxe, SOLANAS, DISCOCERV, Avalon, Illico, BridgePoint, Neocore, ProFuse, AlphaGRAFT, AmnioShield. Alphatec’s subsidiary, Alphatec Spine, designs, develops, manufactures, and markets products for the surgical treatment of spine disorders. The company markets its products in over 50 international markets through its subsidiary, Scient’x via a direct sales force in Italy, and the UK and through independent distributors in the rest of Europe, the Middle East, and Africa. In South America and Latin America the company conducts its operations through its Brazilian subsidiary, Cibramed Productos Medicos. The Company markets its products in Asia through its subsidiary, Alphatec Pacific and its subsidiaries, through a direct sales force and independent distributors, and through distributors in the other parts of Asia and Australia. Alphatec’s research and development (R&D) activities focus on introducing new products to its portfolio to expand its market share in global spine market. In FY2016, the company spent US$9.2 million on its R&D activities, which stood at 7.7% of its total revenue. The company’s other subsidiaries include Alphatec Spine GmbH, Milverton Ltd, Alphatec Holdings International C.V, Japan Ortho Medical, Scient’x U.S.A., Scient’x Australia PTY. LTD., Scient’x Asia Pacific PTE. LTD., Scient’x Italia S.R.L, Scient’x (U.K.) Limited, Cibramed Produtos Medicos Ltda – EPP, and Alphatec International LLC.

Scope of the Report:

About the Company: Historical Details, Current Ownership Structure and basic overview of Balfour Beatty plcin terms of revenue, net income, and operating income.

Financials: Details about Balfour Beatty plclisting status, annual financial reports (for the past 5 years), key financial highlights and region wise and category wise breakdown of their net revenue.

Products/Services: Listing of the company’s entire portfolio along with the description of individual products/services providing a clear picture of their target audience.

Company SWOT Analysis: Outlines Atea ASA.’s strengths, weaknesses, and opportunities and threats facing the company.

Recent Developments: Showcases Atea ASA.’s recent developments including mergers, acquisitions, partnerships, collaborations, new product launches, investment and divestment plans.

Strategic Evaluation: This section provides an overview of Atea ASA.’s corporate goals and strategic initiatives and evaluates their outcomes along with outlining any persisting legal issues and outlook of our in-house analyst panel on the particular company.

Technology Landscape: Details how the company allocates its IT budget across the core areas of its business, CIO/CTO Profile, Key IT Initiatives and Deals undertaken by the company at present along with outlook.

Key Questions Answered

What domain does Balfour Beatty plcoperate and what are key points about it?

What is the product/service portfolio of Atea ASA.?

How has Balfour Beatty plcperformed financially from 2013?

How does Balfour Beatty plcrank among its peers in terms of revenue and market share?

What are Balfour Beatty plcstrengths and weaknesses and what opportunities and threats do it face?

What are Atea ASA.’s main growth strategies and how successful has the company been at implementing them?

What is the in-house technical capability of Atea ASA.? Where does it procure/outsource it?

Reasons to buy

Report delivered in easily accessible PPT format which can be used to gain insights quickly and further prepare presentations of your own

Lean pricing structure ultimately giving you vast access to the unlimited knowledge repository of the company profiles at a very competitive cost

12 hour delivery time fulfilling your urgent requests as per your requirement

On-demand customization options that can completely cater to your needs by focusing the report on given specifics

For More Information, Get Sample of the report:Request Sample

Got Some Questions? Inquire Here:Inquire Before Buying

Get This Report:Purchase Now

For More Details, Contact Provider Directly:

Kevin Stewart
Sales Manager
Research Cosmos
kevin@researchcosmos.com
+1 888 709 8757

Be the first to comment

Leave a Reply